Armata Pharmaceuticals, Inc. — Director's Dealing 2015

Sep 23, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AmpliPhi Biosciences Corp (APHB)
CIK: 0000921114
Period of Report: 2015-09-21

Reporting Person: Kirk Julian P. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-09-21	Option to Purchase Common Stock	$6.38	A	16200	Acquired	2025-09-21	Common Stock (16200)	Direct

Footnotes

F1: The shares underlying this option shall vest and become exercisable in accordance with the following schedule: 6,500 shares will vest on an equal monthly basis over a four year period, commencing on August 3, 2015, the date of the Company's most recent annual meeting of shareholders, and 9,700 shares will vest over the same four year period, subject to the additional requirement that the market price of the common stock of AmpliPhi Biosciences Corporation reach $25.00 per share before the option expires.